(Q39830225)

15 September 2017

title

Combination chemotherapy with 1-methyl-1-nitrosourea (MNU) and cyclophosphamide in solid tumors (English)

1 reference

9 May 2022

1 reference

9 May 2022

author name string

K. Kolarić

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A143813

9 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=143813

9 May 2022

publication date

1 August 1977

1 reference

15 September 2017

15 August 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=143813

full work available at URL

9 May 2022

http://link.springer.com/content/pdf/10.1007/BF00283785.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00283785/fulltext.html

9 May 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00283785

9 May 2022

1 reference

Zeitschrift für Krebsforschung und Klinische Onkologie

9 May 2022

published in

1 reference

15 September 2017

volume

89

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

311-319

1 reference

Use of N-nitroso methylurea in lung cancer

15 September 2017

cites work

1 reference

12 December 2020

Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).

1 reference

12 December 2020

ANTILEUKEMIC ACTIVITY OF HYDROXYUREA (NSC-32065) AND OTHER UREA DERIVATIVES

1 reference

12 December 2020

A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study

1 reference

12 December 2020

[Experimental brain tumors in rabbits following injection of methylnitrosourea]

1 reference

12 December 2020

Chemotherapy of primary malignant brain tumors in children

1 reference

12 December 2020

Activity of cyclophosphamide and 1-methylnitrosourea on Ehrlich carcinoma transplanted in different sites. Correlation between drug level and tumor inhibition

1 reference

12 December 2020

Combined modality therapy for intracranial tumors

1 reference

12 December 2020

Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962

1 reference

12 December 2020

Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909)

1 reference

12 December 2020

Selective chemotherapy in relation to the site of tumor transplantation

1 reference

12 December 2020

Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies

1 reference

12 December 2020

Combination therapy of acute leukemia in rats L 5222 with cytoxan and methyl- or cytoxan and n-butyl-n-nitroso urea (author's transl)

1 reference

12 December 2020

SELECTIVE INDUCTION OF MALIGNANT TUMORS IN THE BRAIN AND SPINAL CORD OF RATS BY N-METHYL-N-NITROSOUREA

1 reference

12 December 2020

Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure

1 reference

12 December 2020

4

25

1876

V.T. DeVita

1965

1 reference

9 May 2022

Identifiers

DOI

10.1007/BF00283785

1 reference

15 September 2017

1 reference